Request Deal Involvement
Access Biotechnology led a $300m Series C round in ACELYRIN.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Principals
bidder
WESTLAKE VILLAGE BIOPARTNERS
bidder
MATRIX CAPITAL MANAGEMENT
bidder
VENBIO LLC
target
ACELYRIN
bidder
TYBOURNE CAPITAL MANAGEMENT LTD
bidder
DECHENG CAPITAL LLC
bidder
SURVEYOR CAPITAL
bidder
SAMSARA BIOCAPITAL
bidder
BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)
bidder
ACCESS BIOTECHNOLOGY
bidder
MARSHALL WACE
bidder
ORBIMED ADVISORS LLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite